CLINICAL_TRIALS
trial_result
· 2019-07-11
Clinical Trial Update: Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat [Phase 3]
Summary
Phase 3 double-blind trial assessing efficacy and tolerance of Ambroxol 20 mg lozenges for sore throat (pharyngitis) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-11